Skip to main content

COVID-19 Topic Center

Diabetes Expert Insights

Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume3, Issue 1 “Pour some sugar on me” SGLT2 inhibitors have morphed into somewhat of a pharmacologic panacea over the last half-decade. First, there was the serendipitous discovery of cardio-protective effects in patients with…
Pharmacy Learning Network
Diabetes is a well-known risk factor for the development of heart failure.1 Pre-diabetes continues to grow in the United States.2 This is important because pre-diabetes associated dysglycemia is associated with abnormal cardiac structure and function, associated with a higher risk of heart failure.…
Pharmacy Learning Network
By Yvette C. Terrie, BS Pharm, RPh, Consultant Pharmacist Metformin is one of the most extensively prescribed drugs used to treat T2DM and is also recommended by the American Diabetes Association (ADA) as the preferred initial pharmacological agent for the treatment of T2DM either alone or in…
Pharmacy Learning Network
By Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd  All of us have experienced various types of acute and chronic pain throughout our lives and, in many cases, we are fortunate to see the pain go away or diminish over time as the body uses…
Pharmacy Learning Network
By Julie Gould Julie Lauffenburger, PharmD, Harvard Medical School and division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital, explains how more intensive insulin-adherence interventions impact patient outcomes and highlights the challenges faced when…
Pharmacy Learning Network
The answer may be yes. Diabetes mellitus has reached panepidemic proportions across the world with approximately 382 million people diagnosed and is set to rise to 592 million by 2040.1 In 2013, half of all premature deaths in adults under the age of 60 were attributable to diabetes. Another 175…
Pharmacy Learning Network
Statins along with aspirin and inhibitors of the renin-angiotensin-renin system are foundational to the treatment of atherosclerotic cardiovascular disease. The National Health and Nutrition Examination Study or NHANES reported that in 2011-2012, 23% of adults over the age of 40 reported using a…
Pharmacy Learning Network
Gestational diabetes (GD) was previously considered the onset of diabetes during pregnancy in patients that have never been diagnosed before the pregnancy. This meant that women tested at any time (first, second, or third trimester) were diagnosed as having GD. However, in the past few years, the…
Pharmacy Learning Network
Incretin based therapies (IBT) continue to grow in popularity as a preferred treatment option for people with type 2 diabetes (T2D). However, it is still common to find confusion between the 2 classes of drugs included in the IBT category. Glucagon-like peptide -1 (GLP1) agonists and dipeptidyl…
Back to Top